All tools

Research & Evidence

Veeva Study Builder Agent logo

Veeva Study Builder Agent

AI agent that configures Veeva EDC forms, visits, edit checks and DQS listings directly from a study protocol, reusing a sponsor's own standards and CDISC USDM.

The Signal

Aims to cut clinical study builds to as little as one day; early adopter availability planned for December 2026 at no extra license cost for EDC customers.

More in Research & Evidence